T. Rowe Price Investment Management, Inc. Pacific Biosciences Of California, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $2.27 Million - $6.18 Million	644,039 Added 8.31%	8,397,820 $31.5 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $2.02 Million - $3.5 Million	338,257 Added 4.56%	7,753,781 $76.1 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $10.2 Million - $17.3 Million	1,243,925 Added 20.16%	7,415,524 $61.9 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $7.49 Million - $10.6 Million	751,036 Added 13.86%	6,171,599 $82.1 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $12.02 $5.16 Million - $7.81 Million	-649,976 Reduced 10.71%	5,420,563 $62.8 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $8.52 Million - $16.8 Million	-1,502,019 Reduced 19.84%	6,070,539 $49.7 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $29.8 Million - $64.9 Million	7,572,558 New	7,572,558 $44 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $434M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.